XML 59 R45.htm IDEA: XBRL DOCUMENT v3.8.0.1
Income Taxes - Schedule of Gross Deferred Tax Asset and Related Valuation Allowance (Detail) - USD ($)
Dec. 31, 2017
Dec. 31, 2016
Deferred tax assets:    
Net operating loss carryforward $ 30,813,509 $ 34,451,814
Capitalized start-up costs 1,695,688 2,708,479
Patent amortization 135,358 216,203
Research and orphan drug credits 21,293,509 14,988,522
Deferred rent 71,938 123,744
Deferred compensation 2,274,885 2,107,964
Other 69,906 70,511
Total gross deferred tax assets 56,354,793 54,667,237
Valuation allowance $ (56,354,793) $ (54,667,237)